<DOC>
	<DOCNO>NCT02434835</DOCNO>
	<brief_summary>The purpose study evaluate absorption , metabolism excretion follow single oral dose [ 14C ] KWA-0711 healthy male subject .</brief_summary>
	<brief_title>Study Absorption , Metabolism Excretion Following Single Oral Dose 14CKWA-0711 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Subjects male , caucasian , 35 55 year age , inclusive . Subjects body mass index ( BMI ) 18.5 30.0 kg/m2 , inclusive . Subjects body weight 50 100 kg , inclusive . Subjects must regular bowel movement . Subjects abnormality heart rate , blood pressure , temperature 12lead ECG . Subjects still participate clinical study participate clinical study involve administration investigational drug 3 month prior dose administration . Subjects clinically significant illness within 4 week dose administration determine Investigator . Subjects clinically significant abnormal laboratory safety finding . Subjects X ray participate clinical trial involve radiolabelled investigational product expose radiolabelled substance within 12 month prior dose administration .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>